chalcone has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baikova, I; Csuk, R; Galimova, Z; Gatilov, Y; Hoenke, S; Kazakova, O; Khusnutdinova, E; Lobov, A; Serbian, I; Thu, HNT; Tuyen, NV | 1 |
| Astuti, I; Bamodu, OA; Huang, WC; Lee, WH; Lin, CM; Su, YK; Suwito, H; Yeh, CT; Zucha, MA | 1 |
| Liu, M; Liu, Y; Qi, Z; Yang, G; Zhang, M | 1 |
| Amerik, AY; Issaenko, OA | 1 |
| Benedetti Panici, P; Bonanno, G; De Vincenzo, R; Delle Monache, F; Ercoli, A; Ferrari, F; Mancuso, S; Piantelli, M; Ranelletti, FO; Scambia, G | 1 |
| Bastow, KF; Itokawa, H; Kilgore, N; Lee, KH; Mishra, L; Nakanishi, Y; Sinha, R; Tachibana, Y | 1 |
6 other study(ies) available for chalcone and Cancer of Ovary
| Article | Year |
|---|---|
Synthesis of messagenin and platanic acid chalcone derivatives and their biological potential.
Topics: Acarbose; Aldehydes; alpha-Glucosidases; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Drug Screening Assays, Antitumor; Female; Humans; Molecular Structure; Ovarian Neoplasms; Ozone; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2022 |
Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.
Topics: Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Chalcone; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphorylation | 2017 |
Tetramethoxychalcone, a chalcone derivative, suppresses proliferation, blocks cell cycle progression, and induces apoptosis of human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Female; G1 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Neoplasm Invasiveness; Ovarian Neoplasms; Polymerization; Resting Phase, Cell Cycle; Signal Transduction; Solubility; Tubulin; Tumor Stem Cell Assay | 2014 |
Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes.
Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Boronic Acids; Bortezomib; Breast Neoplasms; Catalytic Domain; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chalcone; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Endopeptidases; Female; HeLa Cells; Humans; Ovarian Neoplasms; Phenotype; Piperidones; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Tumor Suppressor Protein p53; Ubiquitin Thiolesterase; Ubiquitins | 2012 |
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships.
Topics: Binding Sites; Binding, Competitive; Chalcone; Estradiol; Female; Growth Inhibitors; Humans; Ovarian Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Anti-HIV and cytotoxic activities of Ru(II)/Ru(III) polypyridyl complexes containing 2,6-(2'-benzimidazolyl)-pyridine/chalcone as co-ligand.
Topics: Anti-HIV Agents; Antineoplastic Agents; Chalcone; DNA Replication; DNA, Viral; Drug Screening Assays, Antitumor; Female; Humans; Ligands; Ovarian Neoplasms; Pyridines; Ruthenium; Tumor Cells, Cultured | 2001 |